Efficacy, safety, and tolerability of oral semaglutide versus placebo added to insulin with or without metformin in patients with type 2 diabetes: the PIONEER 8 trial
However, so far across studies with GLP1R agonists , cardiovascular measurements such as blood pressure have seen improvements in general, with no significant increases in adverse cardiovascular effects seen in patients even after 2 years (In fact, decreases were seen), suggesting that the cardiovascular benefits of decreased body weight may overcome any potential harm that increases in heart rate by GLP1R agonists may cause
But if you report stomach pain or other side effects to your healthcare provider, they may want to adjust the dosage
MIC is known to promote fat metabolism and liver function, helping the body break down fats more efficiently, while B12 plays a crucial role in energy production
Compounded Semaglutide Safety Alert - Health Canada Health Canada position on unapproved compounded GLP-1 products and reported safety issues
